S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
SWOG Cancer Research Network
SWOG Cancer Research Network
Takeda
Fondazione Italiana Linfomi - ETS
Centre Antoine Lacassagne
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
SWOG Cancer Research Network
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Mayo Clinic
University of Nebraska
M.D. Anderson Cancer Center
University College, London
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Nebraska
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Celgene
Weill Medical College of Cornell University
SWOG Cancer Research Network
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
SWOG Cancer Research Network
Seagen Inc.
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
SWOG Cancer Research Network
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
Alliance for Clinical Trials in Oncology
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
German High-Grade Non-Hodgkin's Lymphoma Study Group
European Organisation for Research and Treatment of Cancer - EORTC
SWOG Cancer Research Network
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Stanford University
Eli Lilly and Company